Smith & Nephew shares reach new high after reports of J&J bid
This article was originally published in Clinica
Executive Summary
Shares in Smith & Nephew climbed by around 12% on the London Stock Exchange today following unconfirmed media reports that the firm had turned down a $10.9bn bid from Johnson & Johnson.